AlphaStocks
5.0
Consider Buy

Innoviva, Inc. (INVA)

As of Sep 19, 2026, Innoviva, Inc. (INVA) scores 5.0/10 on AlphaStocks' five-model composite, #110 of 168 Health Care stocks.

Health Care / Pharmaceuticals

S&P SmallCap 600

$21.13

Below average on several measures. Research carefully.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 19, 2026

#110out of 168 in Health Care

Is Innoviva, Inc. a Good Investment in 2026?

Innoviva, Inc. (INVA) scores 5.0 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Lynch model rates Innoviva, Inc. as Strong. The Graham model is the least favorable, rating it Attractive. Innoviva, Inc. ranks #110 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E6.6ROE24.8Market Cap2B

Valuation

Trades at 7x earnings — near sector median of 30x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Attractive

Business quality & competitive moat

Graham

Attractive

30% below fair value

Lynch

Strong

Growth rate vs price (PEG)

Greenblatt

Strong

Earnings yield 10.3% · ROC 24%

Frequently Asked Questions

Is Innoviva, Inc. (INVA) a good investment?
As of Sep 19, 2026, Innoviva, Inc. (INVA) scores 5.0/10 on AlphaStocks' five-model composite, #110 of 168 Health Care stocks. That score is below average, suggesting caution. Trades at 7x earnings — near sector median of 30x.
What is Innoviva, Inc.'s Piotroski F-Score?
Innoviva, Inc.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is INVA overvalued or undervalued?
A precise fair value estimate is not available for INVA. Trades at 7x earnings — near sector median of 30x.
How does INVA compare to other Health Care stocks?
Innoviva, Inc. ranks #110 out of 168 stocks in the Health Care sector, placing it in the top 65% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about INVA?
AlphaStocks evaluates INVA using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Attractive; Lynch: Strong; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 5.0/10.

Similar Stocks

AMPHLLYACAD

Compare INVA with

AMPH vs INVAINVA vs LLYACAD vs INVAINVA vs VAL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer